Cobalamin, Folate and Metabolic Syndrome Parameters in Pediatric Morbid Obesity and Metabolic Syndrome

Authors: Mustafa M. Donma, Orkide Donma

Abstract:

Obesity is known to be associated with many clinically important diseases including metabolic syndrome (MetS). Vitamin B₁₂ plays essential roles in fat and protein metabolisms and its cooperation with vitamin B₉ is well-known. The aim of this study is to investigate the possible contributions as well as associations of these micronutrients upon obesity and MetS during childhood. A total of 128 children admitted to Namik Kemal University, Medical Faculty, Department of Pediatrics Outpatient Clinics were included into the scope of this study. The mean age±SEM of 92 morbid obese (MO) children and 36 with MetS were 118.3±3.8 months and 129.5±6.4 months, respectively (p > 0.05). The study was approved by Namık Kemal University, Medical Faculty Ethics Committee. Written informed consent forms were obtained from the parents. Demographic features and anthropometric measurements were recorded. WHO BMI-for age percentiles were used. The values above 99 percentile were defined as MO. Components of MetS [waist circumference (WC), fasting blood glucose (FBG), triacylglycerol (TRG), high density lipoprotein cholesterol (HDL-Chol), systolic pressure (SP), diastolic pressure (DP)] were determined. Routine laboratory tests were performed. Serum vitamin B₁₂ concentrations were measured using electrochemiluminescence immunoassay. Vitamin B₉ was analyzed by an immunoassay analyzer. Values for vitamin B₁₂ < 148 pmol/L, 148-221 pmol/L, > 221 pmol/L were accepted as low, borderline and normal, respectively. Vitamin B₉ levels ≤ 4 mcg/L defined deficiency state. Statistical evaluations were performed by SPSSx Version 16.0. p≤0.05 was accepted as statistical significance level. Statistically higher body mass index (BMI), WC, hip circumference (C) and neck C were calculated in MetS group compared to children with MO. No difference was noted for head C. All MetS components differed between the groups (SP, DP p < 0.001; WC, FBG, TRG p < 0.01; HDL-Chol p < 0.05). Significantly decreased vitamin B₉ and vitamin B₁₂ levels were detected (p < 0.05) in children with MetS. In both groups percentage of folate deficiency was 5.5%. No cases were below < 148 pmol/L. However, in MO group 14.3% and in MetS group 22.2% of the cases were of borderline status. In MO group B₁₂ levels were negatively correlated with BMI, WC, hip C and head C, but not with neck C. WC, hip C, head C and neck C were all negatively correlated with HDL-Chol. None of these correlations were observed in the group of children with MetS. Strong positive correlation between FBG and insulin as well as strong negative correlation between TRG and HDL-Chol detected in MO children were lost in MetS group. Deficiency state end-products of both B₉ and B₁₂ may interfere with the expected profiles of MetS components. In this study, the alterations in MetS components affected vitamin B₁₂ metabolism and also its associations with anthropometric body measurements. Further increases in vitamin B₁₂ and vitamin B₉ deficiency in MetS associated with the increased vitamin B₁₂ as well as vitamin B₉ deficiency metabolites may add to MetS parameters.

Keywords: Children, cobalamin, folate, metabolic syndrome, obesity.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1317248

References:

[1] S. Maffoni, R. De Giuseppe, F. C. Stanford, and H. Cena, “Folate status in women of childbearing age with obesity: a review,” Nutr Res Rev, vol 30, no. 2, pp. 265-271, Dec. 2017.
[2] V.R. da Silva, D. B. Hausman, G. P. A. Kauwell, A. Sokolow, R. L. Tackett, S. L. Rathbun, and L. B. Bailey, “Obesity affects short-term folate pharmacokinetics in women of childbearing age,” Int J Obes, vol. 37, no. 12, pp. 1608-1610, Dec. 2013.
[3] N. Sukumar, S. Wilson, H. Venkataraman, and P. Saravanan, “Low vitamin B12 in pregnancy is associated with maternal obesity and gestational diabetes,” Diab Med, vol. 32, no. SI, pp. 79-80, Mar. 2015.
[4] N. Sukumar, N. Bawazeer, V. Patel, and P. Saravanan, “Low B12 level is associated with maternal obesity and higher birtweight in gestational diabetes,” J Dev Orig Health Dis, vol. 2, no. SI, pp. S128-S129, Sep. 2011.
[5] R. D. Silva, F. M. F. Malta, M. F. F. S. C. Correia, and M. G. P. D. A. Burgos, “Serum vitamin B12, iron and folic acid deficiencies in obese individuals submitted to different bariatric techniques,” ABCD-Braz Arch Dig Surg, vol. 29, suppl.1, pp. 62-66, 2016.
[6] B. A. Knight, B. M. Shields, A. Brook, A. Hill, D. S. Bhat, A. T. Hattersley, and C. S. Yajnik, “Lower circulating B12 is associated with higher obesity and insulin resistance during pregnancy in a non-diabetic white British population,” PLoS ONE, vol. 10, no. 8, Art no. e0135268, Aug. 2015.
[7] E. H. Miranti, R. Stolzenberg-Solomon, S. J. Weinstein, J. Selhub, S. Mannisto, P. R. Taylor, N. D. Freedman, D. Albanes, C. C. Abnet, and G. Murphy, “Low vitamin B12 increases risk of gastric cancer: A prospective study of one-carbon metabolism nutrients and risk of upper gastrointestinal tract cancer,” Int J Cancer, vol. 141, no. 6, pp. 1120-1129, Sep. 2017.
[8] S. Chittiboyina, Z. X. Chen, E. G. Chiorean, L. M. Kamendulis, and B. A. Hocevar, “The role of the folate pathway in pancreatic cancer risk,” PLoS ONE, vol. 13, no. 2 pp. e0193298, Feb. 2018.
[9] S. Kupeli, G. Sezgin, and I. Bayram, “Vitamin B12 and folic acid levels in childhood cancers,” Pediatr Blood Cancer, vol. 63, no.3, pp. S284, Nov. 2016.
[10] R. H. Xie, Y. J. Liu, R. Retnakaran, A. J. MacFarlane, J. Hamilton, G. Smith, M. C. Walker, and S. W. Wen, “Maternal folate status and obesity/insulin resistance in the offspring: a systematic review,” Int J Obes, vol. 40, no. 1, pp.1-9, Jan. 2016.
[11] C. J. Piyathilake, S. Badiga, R. D. Alvarez, E. E. Partridge, and G. L. Johanning, “A lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR in the presence of lower concentrations of plasma folate,” PLoS ONE, vol. 8, no. 1, pp. e54544, 2013.
[12] K. Suriyaprom, B. Phonrat, P. Satitvipawee, A. Tungtrongchitr, and R. Tungtrongchitr, “Homocysteine but not serum amyloid A, vitamin A and E related to increased risk of metabolic syndrome in post-menapausal Thai women,” Int J Vitam Nutr Res, vol. 84, no. 1-2, pp. 35-44, 2014.
[13] M. Narang, M. Singh and S. Dange, “Serum homocysteine, vitamin B12 and folic acid levels in patients with metabolic syndrome,” J Assoc Physicians India, vol. 64, no. 7, pp. 2-26, Jul. 2016.
[14] G. Hergene, A. Onat, S. Albayrak, H. Ozhan, H. Uyarel, and G. Can. “Serum folate and vitamin B12 levels in Turkish women: Inverse associations with metabolic syndrome, but none with coronary heart disease,” Clin Chem, vol 53, no.6, pp.A49, Jun 2007.
[15] S. Ozer, E. Sonmezgoz, and O. Demir, “Negative correlation among vitamin B12 levels, obesity severity and metabolic syndrome in obese children: A case control study,” J Pak Med Assoc, vol. 67, no. 11, pp. 1648-1653, Nov. 2017.
[16] M. Ho, J. H. Halim, M. L. Gow, N. El-Haddad, T. Marzulli, L. A. Baur, C. T. Cowell, and S. P. Garnett, “Vitamin B12 in Obese Adolescents with Clinical Features of Insulin Resistance,” Nutrients, vol. 6, no. 12, pp. 5611-5618, Dec.2014.
[17] L. R. Anastacio, G. L. Ferreira, H. de Sena Riberio, J. C. Liboredo, A. S. Lima, and M. I. Toulson Davisson Correla, “Metabolic syndrome after liver transplantation: prevalence and predictive factors,” Nutrition, vol. 27, no. 9, pp. 931-937, Sep. 2011.
[18] L. Majnaric, F. Babic, A. Lukacova, and A. Holzinger, “The metabolic syndrome characteristics extended by using a machine learning approach,” Atherosclerosis, vol. 241, no. 1, pp. E171, Jul, 2015.
[19] Y. Tamai, K. Wada, M. Tsuji, K. Nakamura, Y. Sahashi, K. Watanabe, K. Yamamoto, K. Ando, and C. Nagata, “ Dietary intake of vitamin B12 and folic acid is associated with lower blood pressure in Japanese preschool children,” Am J Hypertens, vol. 24, no. 11, pp. 1215-1221, Nov. 2011.
[20] S. A. Chiplonkar, V. V. Agte, K. V. Tarwadi, K. W. Paknikar, and U. P. Divata, “Micronutrient deficiencies as predisposing factors for hypertension in lactovegeterian Indian adults,” Am J Coll Nutr, vol. 23, no. 3, pp. 239-247, Jun. 2004.
[21] H. H. Hagar, “Folic acid and vitamin B12 supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats,” Pharmacol Res, vol. 46, no. 3, pp. 213-219, Sep. 2002.